Edwards Lifesciences completes $340 million acquisition of Valtech Cardio

Tim Casey | | Cardiovascular Business | Structural Heart Disease

Edwards Lifesciences completed its acquisition of Valtech Cardio on Jan. 23 for $340 million in stock and cash.

Edwards said in a news release that it could pay an additional $350 million in prespecified milestone-driven payments during the next 10 years. The companies announced on Nov. 28 that they had agreed to the deal.

Valtech Cardio, which is based in Israel, manufactures the Cardioband System for transcatheter repair of the mitral and tricuspid valves. The system is not yet approved by the FDA, but it has received a CE mark in Europe for the mitral valve application.

Valtech is developing mitral regurgitation treatments to allow patients to avoid open heart surgery, according to its website.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
9 key takeaways from AHA 2024 in Chicago
Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves
Edoxaban could limit blood clots, ‘make life easier’ for heart valve surgery patients

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."